MSSM.US Morgan Stanley Pathway Small-Mid Cap Equity ETF
- Total assets
- 702M
- Expense ratio
- 0.62%
- Dividend yield
- 0.55%
- 1-year return
- +17.00%
- Holdings
- 1,808
- Since
- 1991
Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.
What does MSSM.US invest in?
- Mostly US stocks (92.7%)
- Largest sector: Technology (18.2%)
- Largest region: North America (97.9%)
- Top 3 holdings: 2.1% of the fund
Asset allocation
- US stocks 92.7%
- Non-US stocks 2.6%
- Cash 2.2%
- Other 0.0%
- Not classified 0.0%
Top holdings
- Ascendis Pharma AS 0.83%
- ViaSat Inc 0.63%
- KBR Inc 0.63%
- Haemonetics Corporation 0.63%
- BrightSpring Health Services, Inc. Common Stock 0.56%
Morgan Stanley Pathway Small-Mid Cap Equity ETF performance
Sharpe ratio 0.80- This year
- +14.91%
- 1 year
- +17.00%
- 3 years
- +17.29%
- 5 years
- +5.05%
Volatility 16.8% over 1 year and 16.6% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
MSSM.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Morgan Stanley Pathway Small-Mid Cap Equity ETF
The fund will invest, under normal market conditions, at least 80% of its net assets (plus the amount of any borrowing for investment purposes) in the equity securities of small-mid capitalization (or "cap") companies or in other investments with similar economic characteristics. The manager defines small-mid cap companies as companies with market caps not exceeding the highest month-end market cap value of any stock in the Russell 2500® or Russell Mid Cap Index.
Full fund profileMorgan Stanley Pathway Small-Mid Cap Equity ETF top holdings
6.0% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Ascendis Pharma AS ASND.US | Healthcare | United States | 0.83% |
| ViaSat Inc VSAT.US | Technology | United States | 0.63% |
| KBR Inc KBR.US | Industrials | United States | 0.63% |
| Haemonetics Corporation HAE.US | Healthcare | United States | 0.63% |
| BrightSpring Health Services, Inc. Common Stock BTSG.US | Healthcare | United States | 0.56% |
| Dynatrace Holdings LLC DT.US | Technology | United States | 0.56% |
| Moderna Inc MRNA.US | Healthcare | United States | 0.56% |
| Life Time Group Holdings Inc LTH.US | Consumer Cyclical | United States | 0.54% |
| Regal Beloit Corporation RRX.US | Industrials | United States | 0.51% |
| Wintrust Financial Corporation WTFC.US | Financial Services | United States | 0.50% |
The 10 largest of 1,808 holdings.
MSSM.US sector exposure
- Technology18.2%
- Industrials17.7%
- Healthcare17.3%
- Financial Services14.4%
- Consumer Cyclicals9.7%
- Real Estate5.0%
- Utilities4.5%
- Consumer Defensive4.0%
- Energy3.7%
- Basic Materials3.7%
- Communication Services2.6%
Share of the stocks in the fund.
MSSM.US regional exposure
- North America97.9%
- Europe Developed0.7%
- Latin America0.5%
- Africa/Middle East0.4%
- Asia Emerging0.2%
- United Kingdom0.1%
- Asia Developed0.0%
Share of the stocks in the fund.
Company size
Average market cap 6.95B- Mega cap0.0%
- Big cap0.2%
- Medium cap18.2%
- Small cap55.1%
- Micro cap22.9%
Morgan Stanley Pathway Small-Mid Cap Equity ETF fund profile
- Fund name
- Morgan Stanley Pathway Small-Mid Cap Equity ETF
- Ticker
- MSSM.US
- Exchange
- USA Stocks
- Issuer
- Morgan Stanley
- Index tracked
- -
- Category
- US Small & Mid Cap Equity
- Inception date
- Nov 18, 1991
- Trading currency
- USD
- Expense ratio
- 0.62%
About Morgan Stanley Pathway Small-Mid Cap Equity ETF
The fund will invest, under normal market conditions, at least 80% of its net assets (plus the amount of any borrowing for investment purposes) in the equity securities of small-mid capitalization (or "cap") companies or in other investments with similar economic characteristics. The manager defines small-mid cap companies as companies with market caps not exceeding the highest month-end market cap value of any stock in the Russell 2500® or Russell Mid Cap Index.